Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mai Hirokawa"'
Autor:
Yasukawa Hidehito, Hiroko Shibata, Masato Kiyoshi, Hiroaki Murase, Takuma Ojima, Taiichiro Ogawa, Takashi Kumagai, Susumu Uchiyama, Yukari Itakura, Shuntaro Saito, Hiroyuki Suetomo, Takahiro Maruno, Naoki Mori, Hirotaka Nishimura, Satoshi Saitoh, Kazuhiro Takegami, Yuuka Asano, Akiko Ishii-Watabe, Akira Harazono, Momoko Takeuchi, Mai Hirokawa, Aya Kikitsu, Takafumi Iwura, Tetsuo Torisu, Okabe Shinji, Michiko Akimaru, Atsushi Oda, Keisuke Ikemoto
Publikováno v:
Journal of Pharmaceutical Sciences. 108:832-841
The evaluation of subvisible particles, including protein aggregates, in therapeutic protein products has been of great interest for both pharmaceutical manufacturers and regulatory agencies. To date, the flow imaging (FI) method has emerged as a pow
Autor:
Mai Hirokawa, Tomomi Akita, Hitomi Sakai, Michiko Horiguchi, Isao Tachibana, Harumi Kumagai, Yoshito Takeda, Yuki Oiso, Norikazu Maeda, Chikamasa Yamashita, Chihiro Ozawa
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 361:501-505
Chronic obstructive pulmonary disease (COPD) is an intractable pulmonary disease that causes widespread and irreversible alveolar collapse. Although COPD occurs worldwide, only symptomatic therapy is currently available. Our objective is the developm
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 201
Chronic obstructive pulmonary disease (COPD) is a major cause of death worldwide. However, no drugs can regenerate lung tissue in COPD patients, and differentiation-inducing drugs that can effectively treat damaged alveoli are needed. In addition, th
Publikováno v:
Journal of Controlled Release. 233:191-197
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disease with several causes, including smoking, and no curative therapeutic agent is available, particularly for destructive alveolar lesions. In this study, we investigated th
Autor:
Tomomi Akita, Yusuke Nakao, Kaori Abe, Chihiro Ozawa, Mai Hirokawa, Michiko Horiguchi, Chikamasa Yamashita
Publikováno v:
Insights in Chest Diseases.
Pulmonary emphysema is a disease in which alveoli in the lung are irreversibly destroyed, compromising lung function. All-trans-retinoic acid (ATRA) reportedly repairs the alveoli of emphysema model mice. In addition, ATRA can activate two nuclear re